28473015|t|MESOTHELIAL CELL ADHERENCE TO VASCULAR PROSTHESES AND THEIR SUBSEQUENT GROWTH IN VITRO
28473015|a|Cell seeding may decrease the thrombogenicity of implanted vascular grafts, but its application is hampered by the limited availability of autologous endothelial cells. Human peritoneal mesothelial cells have blood flow supporting qualities and are readily available. This study investigated the adherence of mesothelial cells to vascular prostheses and their subsequent growth in vitro. Circular pieces of various vascular prosthetic materials were seeded with 51Chromium-labeled mesothelial and endothelial cells and left for either 5, 15, 30, 60, and 120 minutes. The unattached cells were removed and the degree of cell attachment was measured. The number of mesothelial cells to Dacron increased during the first 60 min up to 35.2 % of the seeded inoculum where after a plateau was reached. Scanning electron microscopy showed spreaded mesothelial cells adherent to the Dacron fibers. A significant increase in adherence was observed after preincubation of Dacron with 10 Î¼g/mL fibronectin, but no improvement was found after preincubation with human serum albumin or gelatin. Mesothelial cells adhered better to Gelcoated than to Gelsealed or plain Dacron. The adherence of mesothelial cells to ePTFE (Teflon) was significantly poorer. No significant differences in adherence were found between mesothelial and endothelial cells. Mesothelial cell growth on Dacron resulted in a modest increase in the number of viable cells during 27 days, which implies biocompatibility of Dacron and mesothelial cells in vitro.
28473015	0	16	MESOTHELIAL CELL	T025	C0225335
28473015	17	26	ADHERENCE	T169	C0334154
28473015	30	49	VASCULAR PROSTHESES	T074	C0005846
28473015	60	70	SUBSEQUENT	T079	C0332282
28473015	71	77	GROWTH	T040	C0018270
28473015	78	86	IN VITRO	T080	C1533691
28473015	87	91	Cell	T025	C0007634
28473015	92	99	seeding	T059	C1705192
28473015	104	112	decrease	T081	C0547047
28473015	117	132	thrombogenicity	T046	C0040053
28473015	136	145	implanted	T074	C0021102
28473015	146	161	vascular grafts	T074	C0879126
28473015	210	225	availability of	T169	C0470187
28473015	226	236	autologous	T080	C0439859
28473015	237	254	endothelial cells	T025	C0225336
28473015	256	261	Human	T016	C0086418
28473015	262	272	peritoneal	T029	C0442034
28473015	273	290	mesothelial cells	T025	C0225335
28473015	296	306	blood flow	T039	C0232338
28473015	307	327	supporting qualities	T080	C0332306
28473015	336	353	readily available	T169	C0470187
28473015	366	378	investigated	T169	C1292732
28473015	383	392	adherence	T169	C0334154
28473015	396	413	mesothelial cells	T025	C0225335
28473015	417	436	vascular prostheses	T074	C0005846
28473015	447	457	subsequent	T079	C0332282
28473015	458	464	growth	T040	C0018270
28473015	465	473	in vitro	T080	C1533691
28473015	475	483	Circular	T082	C1282913
28473015	484	490	pieces	T081	C2982836
28473015	502	510	vascular	T080	C1801960
28473015	511	531	prosthetic materials	T122	C0444752
28473015	537	543	seeded	T059	C1705192
28473015	549	567	51Chromium-labeled	T121,T130,T196	C0303212
28473015	568	579	mesothelial	T025	C0225335
28473015	584	601	endothelial cells	T025	C0225336
28473015	645	652	minutes	T079	C0439232
28473015	658	668	unattached	T033	C3841381
28473015	669	674	cells	T025	C0007634
28473015	680	687	removed	T080	C0849355
28473015	696	702	degree	T081	C0449286
28473015	706	710	cell	T025	C0007634
28473015	711	721	attachment	T052	C1947904
28473015	726	734	measured	T080	C0444706
28473015	740	746	number	T081	C0237753
28473015	750	767	mesothelial cells	T025	C0225335
28473015	771	777	Dacron	T109,T122	C0947693
28473015	778	787	increased	T081	C0205217
28473015	808	811	min	T079	C0439232
28473015	832	838	seeded	T059	C1705192
28473015	839	847	inoculum	T167	C0439861
28473015	862	869	plateau	T081	C2964353
28473015	874	881	reached	T033	C0243095
28473015	883	911	Scanning electron microscopy	T059	C0026020
28473015	919	927	spreaded	T080	C0332261
28473015	928	945	mesothelial cells	T025	C0225335
28473015	946	954	adherent	T169	C0334154
28473015	962	975	Dacron fibers	T109,T122	C0947693
28473015	979	990	significant	T078	C0750502
28473015	991	999	increase	T169	C0442805
28473015	1003	1012	adherence	T169	C0334154
28473015	1017	1025	observed	T169	C1441672
28473015	1032	1045	preincubation	T059	C0022885
28473015	1049	1055	Dacron	T109,T122	C0947693
28473015	1070	1081	fibronectin	T116,T123	C0016055
28473015	1087	1101	no improvement	T033	C3844714
28473015	1106	1111	found	T033	C0150312
28473015	1118	1131	preincubation	T059	C0022885
28473015	1137	1142	human	T016	C0086418
28473015	1143	1156	serum albumin	T116	C0036773
28473015	1160	1167	gelatin	T116,T121,T122	C0017237
28473015	1169	1186	Mesothelial cells	T025	C0225335
28473015	1187	1194	adhered	T067	C3714578
28473015	1205	1214	Gelcoated	T080	C1522408
28473015	1223	1232	Gelsealed	T080	C0205556
28473015	1236	1248	plain Dacron	T109,T122	C0947693
28473015	1254	1263	adherence	T169	C0334154
28473015	1267	1284	mesothelial cells	T025	C0225335
28473015	1288	1293	ePTFE	T109,T122	C0015312
28473015	1295	1301	Teflon	T109,T122	C0699518
28473015	1307	1320	significantly	T078	C0750502
28473015	1321	1327	poorer	T080	C2700379
28473015	1329	1343	No significant	T033	C1273937
28473015	1344	1355	differences	T080	C1705242
28473015	1359	1368	adherence	T169	C0334154
28473015	1374	1379	found	T033	C0150312
28473015	1388	1399	mesothelial	T025	C0225335
28473015	1404	1421	endothelial cells	T025	C0225336
28473015	1423	1439	Mesothelial cell	T025	C0225335
28473015	1440	1446	growth	T040	C0018270
28473015	1450	1456	Dacron	T109,T122	C0947693
28473015	1457	1465	resulted	T169	C1274040
28473015	1471	1486	modest increase	T169	C0442805
28473015	1494	1500	number	T081	C0237753
28473015	1504	1516	viable cells	T025	C1441322
28473015	1527	1531	days	T079	C0439228
28473015	1547	1563	biocompatibility	T044	C0596177
28473015	1567	1573	Dacron	T109,T122	C0947693
28473015	1578	1595	mesothelial cells	T025	C0225335
28473015	1596	1604	in vitro	T080	C1533691